Cargando…
Factors affecting in-stent restenosis after angioplasty with the Enterprise stent for intracranial atherosclerotic diseases
This study investigated factors affecting the safety and in-stent restenosis after intracranial stent angioplasty using the Enterprise stent for symptomatic intracranial atherosclerotic stenosis. Between January 2017 and March 2019, patients with intracranial atherosclerotic stenosis treated with En...
Autores principales: | Zhang, Kun, Li, Tian-Xiao, Wang, Zi-Liang, Gao, Bu-Lang, Gu, Jian-Jun, Gao, Hui-Li, Wang, Yong-Feng, Xia, Jin-Chao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131349/ https://www.ncbi.nlm.nih.gov/pubmed/34006896 http://dx.doi.org/10.1038/s41598-021-89670-x |
Ejemplares similares
-
Intracranial Angioplasty with Enterprise Stent for Intracranial Atherosclerotic Stenosis: A Single-Center Experience and a Systematic Review
por: Sun, Bowen, et al.
Publicado: (2021) -
Neovascularization in Human Intracranial Atherosclerotic In-Stent Restenosis
por: Feng, Yiding, et al.
Publicado: (2021) -
Matrix metalloproteinase 9 level as an indicator for restenosis following cervical and intracranial angioplasty and stenting
por: Liu, Jun-peng, et al.
Publicado: (2015) -
Enterprise stent for symptomatic complex intracranial atherosclerotic stenosis: safety and efficiency
por: Dong, Yanhua, et al.
Publicado: (2019) -
Feasibility and Safety of Paclitaxel-Coated Balloon Angioplasty for the Treatment of Intracranial Symptomatic In-Stent Restenosis
por: Xu, Haowen, et al.
Publicado: (2020)